Connected Health Conference
25-27 October, Seaport World Trade Center, 200 Seaport Boulevard, Boston
The eighth annual Connected Health Conference, presented by the Personal Connected Health Alliance (PCHAlliance) in partnership with Partners Connected Health, is coming up in just a few days.
Wednesday is packed with special sessions that cover the state of the market in wearables, artificial intelligence (AI), voice-activated technologies, the smart home (hosted by Parks Associates) and the innovation economy.
- The Life Sciences and MedTech Roundtable will explore the emerging category of digital therapeutics, the evolution of traditional pharma and med tech business models and the impact on relationships with patients, providers and other stakeholders in healthcare.
- Europe Meets North America will exchange views and strategies on issues like interoperability and the free flow of data across borders in an all-day workshop hosted by the ECHAlliance. (For more on the PCHAlliance’s EU efforts to ensure consistent regulations governing digital health with the implementation of the General Data Protection Regulation (GDPR), see this release.)
Recent additions to the main conference on Thursday and Friday:
- A new fifth track focusing on health system innovation projects, outcomes and processes with the leading partnerships that are disrupting and redesigning healthcare delivery, including Healthbox and Intermountain Healthcare, Brigham Digital Innovation Hub, Johns Hopkins Medicine Technology Innovation Center and MITRE sharing their work with Dana-Farber.
- The new Innovation Lounge will showcase provider, industry and institutional innovation centers and novel collaborations. The Innovation Lounge stage will present groundbreaking initiatives from Intel, IBM, MDRevolution and Becton Dickinson, HHS Idea Lab, data from the IPSOS Digital Doctor Survey, and results of a recent connected health survey. Dr. Joseph Kvedar will share a preview of his new book, The New Mobile Age, How Technology Will Extend the Healthspan and Optimize the Lifespan. (more…)
If the rosy future of mHealth apps [study here] is to be achieved, some form of validation and review is needed, but is ‘pay to play’ the way to go?. The Journal of Medical Internet Research has come up with a peer review process which gives, in the words of mHealthNews, “developers a chance to have their products evaluated by “medical and mHealth experts from the JMIR peer-reviewer database (possibly complemented by consumers/patient experts) for a cool $2,500 per app.” Aside from the price, (more…)
The ‘discrimination’ noted here comes from a study published this month in the Journal of Medical Internet Research’s mHealth and uHealth (JMIR), which attempts to cross-reference ‘high-income country’ and ‘low- and middle-income countries’ diseases with the number of apps available for those diseases. The count is based on a review of literature and apps stores. Unfortunately the study, as reported in FierceMobileHealthcare, sounds quite broad-brush. In general, they assert, there are more apps for high-income country diseases such as dementia and ischemic heart disease. Apps for low-income country diseases, such as lower respiratory diseases and malaria, are fewer. Exceptions are apps for HIV/AIDS, which disproportionately affects low income countries but are abundant, and the dearth of apps for trachea, bronchus and lung cancers prevalent in high and middle-income countries. No mention of whether certain diseases are more effectively controlled by app usage than others, though. JMIR study.
[grow_thumb image=”http://telecareaware.com/wp-content/uploads/2014/01/screen-shot-2014-01-10-at-3-00-24-am.png” thumb_width=”150″ /]Better than a ‘malaria app’
would be eradication, and a step towards this is rapid, accurate and inexpensive analysis of this increasingly drug-resistant disease. A Newcastle, UK company, QuantuMDx
, founded by molecular biologist Jonathan O’Halloran, will be crowdfunding a miniature malaria blood testing device called Q-POC
, which takes a blood sample; through DNA sequencing provides a malaria diagnosis and screens for drug resistance in a record 15 minutes, without running water or stable electricity. The crowdfunding on Indiegogo starting 12 February is to fund the device through clinical trials. Eventual markets are Brazil, India and Africa, then to extend the technology to TB, STDs and cardiovascular disease. MedCityNews